Implementation report on the Commission Communication on Rare Diseases published September 5, 2014. Read more...
Act now: Contact your MEP and ask them to support and ask ECDA's questions to Commissioners designate
PBC is a rare liver disease that primarily results from autoimmune destruction of the bile ducts. Women account for about 90% of PBC cases. Read more...
Now 4063 members from 106 countries
Hepatitis B and C in Mediterranean and Balkan Countries
Venue and dates
December 5-7, 2012
Nicosia Cyprus
Course organisers

The Conference on Hepatitis B and C in Mediterranean and Balkan Countries has united a range of stakeholders to urge the formulation and implementation of effective policies and targeted actions by national governments, healthcare providers and civil society in the fight against hepatitis B and C.

The Conference commends previous work in the domain of hepatitis B and C, in particular the 63rd World Health Assembly’s resolution on Viral Hepatitis of May 2010, MEP Thomas Ulmer’s Call to Action on Hepatitis B launched at the European Parliament in 2006, the European Parliament’s Written Declaration on Hepatitis C in 2007, the Call to Action launched at the Brussels Conference on Hepatitis B and C in Europe in 2010 and the WHO Prevention and Control of Viral Hepatitis Infection: Framework for Global Action, launched in July 2012.

This Call to Action is endorsed by:

Takis Hatzigeorgiou MEP
Stephen Hughes MEP

Alojz Peterle MEP

Viral Hepatitis Prevention Board

European Association for the Study of the Liver

European Liver Patients Association
World Hepatitis Alliance
International Centre for Health, Migration and Development
Hepatitis B and Public Policy Association.

Document to download
Share